Your browser doesn't support javascript.
loading
Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications.
Minuto, Michele N; Berti, Piero; Miccoli, Mario; Ugolini, Clara; Matteucci, Valeria; Moretti, Manuela; Basolo, Fulvio; Miccoli, Paolo.
Affiliation
  • Minuto MN; Department of Surgery, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy. micheleminuto@hotmail.com
Surg Endosc ; 26(3): 818-22, 2012 Mar.
Article in En | MEDLINE | ID: mdl-22038162
ABSTRACT

BACKGROUND:

The first report of minimally invasive video-assisted thyroidectomy (MIVAT) was published in 1999, and the indications were progressively implemented from cytologically undetermined thyroid nodules to intermediate-risk differentiated thyroid cancers. The aim of this study was to review the entire series of patients who underwent a MIVAT, critically analyzing its indications and contraindications and trying to figure out how the indications might be extended.

METHODS:

From 1998 to 2009, a total of 1,946 patients (1,659 females, 287 males; mean age = 40.2 years) underwent MIVAT in our department. Inclusion criteria were benign thyroid nodules <35 mm, malignant nodules <20 mm, and an ultrasonographically estimated thyroid volume (ETV) <25 cc. The presence of suspicious or metastatic lymph nodes and the presence of severe thyroiditis were considered a contraindication for MIVAT.

RESULTS:

A total thyroidectomy was performed in 1,435 patients (72.3%). A total lobectomy was performed in 511 cases (26.3%), and a central neck node sampling was associated with total thyroidectomy in 104 cases. Final histology revealed benign disease in 979 cases (51.5%) and a malignancy was diagnosed in 915 cases (48.5%). Unexpected thyroiditis was found on final histology in 17.9% of the patients with benign disease and 30.9% of patients with malignancy. The incidence of thyroiditis was significantly different in these two populations (p < 0.0001).

CONCLUSION:

Our data confirm the validity of the traditional indications for MIVAT low-risk differentiated thyroid cancer (DTC), cytologically undetermined nodules, and small-volume benign thyroid disease. The indications may be further and safely extended to those patients with associated thyroiditis and those with intermediate-risk DTC. MIVAT can be proposed on a much larger scale than it was at its onset and cannot be considered an option for only a limited number of patients.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Thyroidectomy / Thyroiditis / Thyroid Neoplasms / Video-Assisted Surgery Type of study: Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Thyroidectomy / Thyroiditis / Thyroid Neoplasms / Video-Assisted Surgery Type of study: Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Year: 2012 Type: Article